Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

InfraReDx’s Long Road To Commercialization Continues With Latest Financing

This article was originally published in Start Up

Executive Summary

InfraReDx raised $25 million in late August, another step in its long journey to change the standard of care for coronary artery disease. With the latest financing, the company has raised some $175 million since its founding in 1998, and although it still has far to go, in that length of time InfraReDx, and an understanding of coronary artery disease, have come a long way.

Advertisement

Related Content

Medtech 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models
Medtech In 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models
Boston Sci Links With Guidewire Specialist In Pursuit Of 2015 FFR Launch
InfraReDx: Saved by Angels (and a VC)

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT037913

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel